Cochrane Evidence Synthesis and Methods ►

Immunotherapy for non-small cell lung cancer in the elderly population: a generic protocol

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To evaluate the effectiveness and safety of immune checkpoint inhibitors (ICI) as monotherapy or in combination (with chemotherapy or immunotherapy) compared to chemotherapy for elderly people (≥ 65 years) with non-small cell lung cancer (NSCLC).

This is a protocol.

Health topics:

Lungs & airways > Lung cancer > General aspects of treatment

Published:

19 May 2021

Authors:

Marchal C, Orillard E, Calais F, Westeel V

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Marchal C, Orillard E, Calais F, Westeel V. Immunotherapy for non-small cell lung cancer in the elderly population: a generic protocol (Protocol). Cochrane Database of Systematic Reviews 2021, Issue 5. Art. No.: CD014907. DOI: 10.1002/14651858.CD014907.